TOP2A is highly expressed in many tumor types, such as non-small cell lung cancer, hepatocellular carcinoma, and has proven to be a reliable profile marker, associated with disease progression and poor prognosis [36]. Here, TOP2A is linked to hepatocellular carcinoma.